Meropenem Steriscience

Meropenem, the active ingredient in Meropenem Steriscience, is a carbapenem antibiotic presented as a sterile powder for intravenous use. It treats severe bacterial infections such as intra‑abdominal infections, urinary tract infections, pneumonia, meningitis and sepsis in hospitalized patients.

GNH USA supplies Meropenem Steriscience as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres and specialty clinics worldwide. The product meets EU quality standards, is manufactured under GMP conditions, and is distributed through a regulated supply chain to ensure product integrity.

Meropenem is a broad‑spectrum carbapenem antibiotic used for serious bacterial infections affecting various organ systems.

- Complicated intra‑abdominal infections: provides bactericidal activity against mixed aerobic and anaerobic pathogens, facilitating infection resolution. - Complicated urinary tract infections: eradicates resistant Gram‑negative organisms, helping restore urinary tract sterility. - Nosocomial pneumonia: treats hospital‑acquired lung infections caused by multidrug‑resistant bacteria, improving respiratory function. - Bacterial meningitis: penetrates the cerebrospinal fluid to eliminate causative pathogens, supporting neurological recovery. - Sepsis: offers rapid bacterial killing in systemic infection, aiding hemodynamic stabilization.

Adverse reactions to Meropenem Steriscience may vary in frequency and severity.

Common Side Effects: - Nausea: mild gastrointestinal discomfort. - Diarrhea: loose stools that may lead to dehydration. - Rash: mild skin erythema or itching. - Elevated liver enzymes: transient increase in ALT/AST.

Serious or Rare Side Effects: - Anaphylaxis: severe allergic reaction with respiratory compromise. - Seizures: risk increased in patients with renal dysfunction. - Clostridioides difficile colitis: severe intestinal infection. - Neutropenia: significant drop in white blood cell count.

When using Meropenem Steriscience, consider the following precautions: - Renal function: adjust dose in patients with impaired kidney function. - Hypersensitivity: avoid in individuals with known carbapenem or β‑lactam allergy. - Pregnancy: use only if benefits outweigh potential risks, as safety data are limited. - Concomitant nephrotoxic drugs: monitor renal parameters when combined with aminoglycosides or vancomycin. - Electrolyte monitoring: watch for hypokalemia during prolonged therapy. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Meropenem may interact with other medicines; monitor patients accordingly.

Major Interactions (Avoid): - Valproic acid: may reduce serum valproate levels, risking seizure breakthrough. - High-dose aminoglycosides: increased risk of nephrotoxicity. - Loop diuretics: may exacerbate electrolyte disturbances.

Moderate Interactions (Monitor Closely): - Warfarin: potential alteration of INR, monitor coagulation. - Probenecid: may increase meropenem plasma concentrations. - Oral contraceptives: possible reduction in efficacy, advise additional contraception.